



Assessment of treatment effects  
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SUMMARY
Laser speckle contrast analysis (LASCA) is a good tool to evaluate the variation in peripheral blood perfu-
sion during long-term follow-up and is able to safely monitor digital ulcer evolution in scleroderma patients. 
It evaluates blood perfusion in different areas within the skin lesions and surrounding them during standard 
treatment.
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A 57 year-old female (M.E.) presented to 
our Rheumatology Outpatient Service in 
February 2012, with a digital periungual 
ulcer on her third left finger, severe Rayn-
aud’s phenomenon and joint pain that had 
been affecting her hand and wrists for a 
two-year period. Her condition had previ-
ously been controlled by her GP with pain-
killers. She was an ex-smoker and, in 2011, 
had a traumatic fracture of the second fin-
ger of her left hand. 
Physical examination evidenced a periun-
gual ulcer on her third left fingertip, puffy 
fingers, Raynaud’s phenomenon, initial 
sclerodactily and facial telangiectasia. She 
also had a swollen right wrist and some 
painful metacarpophalangeal joints. 
Laboratory tests revealed positive antinu-
clear antibodies (titre 1:640, with a homo-
geneous and nucleolar indirect immune-
fluorescence pattern) and facial telangiec-
tasia. Blood tests evidenced a rise in the in-
flammatory markers: erythrocyte sedimen-
tation rate, C-reactive protein and gamma 
globulin protein percentage (54 mm/1 h, 
10 mg/L, and 21% respectively). More-
over, there was a slight consumption of C3 
complement fraction (0.84 g/L). The other 
laboratory tests, which included renal and 
liver function tests, rheumatoid factor and 
anti-citrullinated protein antibodies, were 
unremarkable. Nailfold videocapillaros-
copy (NVC) was performed to evaluate 
Raynaud’s phenomenon (1-4). The NVC 
examination demonstrated a scleroderma-
pattern, characterized by an early pattern 
of microangiopathy, with a few giant capil-
laries, a few capillary haemorrhages and a 
relatively well-preserved capillary distribu-
tion, without evident capillary loss (Figure 
1A) (5-7). 
In 2012 a diagnosis of systemic sclerosis 
(SSc) was made according to the LeRoy 
2001 criteria (8). Disease severity was as-
sessed by several instrumental examina-
tions: chest X-ray, spirometry, oesopha-
geal manometry, which were all within the 
normal range, renal Doppler echography 
that showed normal renal artery resistive 
indexes, and heart echography that showed 
no pathological findings; estimated sPAP 
was 27 mmHg. 
Treatment was planned with iloprost 
(continuous 5-day intravenous infusion), 
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bosentan (65 mg twice daily which was in-
creased after one month to 125 mg twice 
daily), methotrexate (10 mg/week) and an-
algesic drugs (tramadol 50 mg/day) (9-10). 
Before starting the pharmacological treat-
ment, laser speckle contrast analysis (LAS-
CA) was performed to evaluate both the 
extension and perfusion of the ulcer area 
(Figure 2A) (11-14).
Her symptoms gradually improved over a 
two-month period, with progressive nor-
malization of the inflammatory markers. 
Her digital ulcer made progressive recov-
ery and her skin blood perfusion increased, 
as evidenced by a control LASCA exami-
nation (Figure 2B). 
During a follow-up visit in 2014, the pa-
tient had an increase in renal artery resis-
tive indexes and was started on ramipril at 
5 mg/day. In 2015, her NVC switched to an 
active pattern of microangiopathy with fre-
quent giant capillaries, frequent capillary 
haemorrhages and a moderate capillary 
loss (Figures 1B) (5-7). The patient had no 
new digital ulcers.
The patient was put on cyclic intravenous 
iloprost for Raynaud’s phenomenon, but in 
2016, she was no longer able to continue 
the therapy prescribed due to problems at 
her workplace. Therefore, aminaphtone 
(75 mg twice daily) was started off-label, 
in combination with her other treatment 
(bosentan, methotrexate and ramipril). 
Raynaud condition score, frequency and 
duration of Raynaud’s attacks and LAS-
CA were performed at baseline (T0) and 
after four (T4) weeks of treatment, at the 
level of her hands to evaluate her clinical 
condition (Figure 3). Treatment with ami-
naphtone improved the symptoms related 
to Raynaud’s phenomenon, and the blood 
perfusion in all skin areas improved rapidly 
(Figure 3, T4).
At time of writing the NVC status and or-
gan involvement have not changed since 
2015 and the patient has had no new digital 
ulcers since 2013. 
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Figure 1 - Nailfoild videocapillaroscopic patterns of scleroderma mi-
croangiopathy (200x) in our patient (ME), showing an Early pattern in 
2012 (A), and an Active pattern in 2015 (B). 
Figure 2 - LASCA images (3rd finger) of active 
ulcer before (A) and after two months’ treat-
ment (B), at the fingertip level. Scan image: 
blue = low blood perfusion (BP), yellow = in-
termediate BP, red = high BP.
Figure 3 - LASCA images of the dorsum and 
palm of the hand in our SSc patients before 
(T0) and at four weeks (T4) of treatment with 
Aminapthone. Perfusion is reported as perfu-
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